Overview
Michael Neuss is a Hematologist Oncology specialist and an Oncologist in Nashville, Tennessee. Dr. Neuss has been practicing medicine for over 41 years and is rated as an Experienced provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Neuss is currently accepting new patients.
His clinical research consists of co-authoring 92 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Chronic Lymphocytic Leukemia (CLL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Tennessee Oncology PLLC
Ian Flinn is a Hematologist Oncology specialist and a Hematologist in Tullahoma, Tennessee. Dr. Flinn is rated as an Elite provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Flinn is currently accepting new patients.
Sarah Cannon Research Institute
Dr. Patel joined SCRI in 2024, as director of lymphoma research, and oversees SCRI’s comprehensive lymphoma clinical trial portfolio. Previously, he served as the Director of Hematologic Malignancies and Cell Therapy at the Swedish Cancer Institute in Seattle, Washington, where he led development of the program’s clinical standards for lymphoma care, assisted in the expansion of cell therapy services, and helped shape lymphoma research efforts. Dr. Patel was also a member of the Paul G. Allen Research Center at Seattle Cancer Institute, serving as a co-founding member of the Center for Immuno-oncology, where he collaborated on translational research related to immunotherapy in hematologic diseases.Dr. Patel has been published in various medical journals, including New England Journal of Medicine, Blood, and Journal of Clinical Oncology. He is also a member of the ASCO Cancer Communications Committee, the CIBMTR Lymphoma Working Committee, and the National Planning Committee for the Lymphoma Research Foundation Lymphoma Rounds. His clinical and research focus is in lymphomas, CLL, and cellular therapy. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Vanderbilt Health Clinicians, LLC
Nishitha Reddy is a Hematologist Oncology specialist and an Oncologist in Nashville, Tennessee. Dr. Reddy is rated as a Distinguished provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Small Lymphocytic Lymphoma (SLL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Reddy is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Neuss isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Neuss isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Neuss isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- AstrocytomaDr. Neuss isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- EGFR Positive Lung CancerDr. Neuss isAdvanced. Learn about EGFR Positive Lung Cancer.
- Embryonal Tumor with Multilayered Rosettes
- Familial Prostate CancerDr. Neuss isAdvanced. Learn about Familial Prostate Cancer.
- Experienced
- Acute Eosinophilic PneumoniaDr. Neuss isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Neuss isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Mountain SicknessDr. Neuss isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Neuss isExperienced. Learn about Acute Myeloid Leukemia (AML).